Study confirms high success rates of combined chemotherapy in treating testicular cancer

FHS
July 20, 2024
2:48 am

A new study shows that by combining different chemotherapy drugs, testicular cancer remains highly treatable and often curable, even after first-line treatment fails.

Chemo Shortage Fuels Price Gouging; MDS Misdiagnoses; Risky Accelerated Approvals?

The shortage of key chemotherapy drugs has led to price gouging, forcing some hospitals to pay as much as 10 times the usual cost. (NBC

August 19, 2023

Researchers uncover new mechanism of action between nutrient adaptation of intestinal stem cells and aging

The capacity of intestinal stem cells to maintain cellular balance in the gut decreases upon aging.

February 12, 2024

Study reveals gaps in interconception care for Australian mothers

Some Australian mothers regard navigating their personal health care in between pregnancies as confusing, inconsistent, and hard to access, new research by a Monash University-led team

November 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.